Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Biotechnology
  • Inflammation biotech Electra charges up with $350M from upsized IPO

Inflammation biotech Electra charges up with $350M from upsized IPO

September 18, 2026Posted inBiotechnology

Electra Therapeutics is the latest biotech to overshoot its own IPO expectations this year, with the inflammation-focused company bringing in $350 million from this morning’s Nasdaq listing.

Post navigation

Previous Post
kidney-organoids-reveal-inflammatory-drivers-of-diabetic-kidney-disease Kidney Organoids Reveal Inflammatory Drivers of Diabetic Kidney Disease
Next Post
BMS dumps $100M Orum degrader-antibody conjugate after glimpsing phase 1 data

Recent Posts

  • Xenon pauses phase 3 depression trials after psychosis events
  • BMS dumps $100M Orum degrader-antibody conjugate after glimpsing phase 1 data
  • Inflammation biotech Electra charges up with $350M from upsized IPO
  • Kidney Organoids Reveal Inflammatory Drivers of Diabetic Kidney Disease
  • Molecular Devices and STEMCELL Technologies Team Up to Automate Organoid Research

Archives

  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • March 2024
  • January 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top